Vytorin And Zetia Draw Suits And Scrutiny
The stakes are high for Merck & Co. and Schering-Plough Corp. as they face proposed class actions and a congressional inquiry over doubts of the effectiveness of their cholesterol drugs, Vytorin...To view the full article, register now.
Already a subscriber? Click here to view full article